Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively

Minimal clinically important differences in health-related quality of life after total hip or knee replacement

(2013) J. C. Keurentjes et al.   Bone & Joint Research

Feasibility of 4 patient-reported outcome measures in a registry setting

(2012) Aksel Paulsen et al.   Acta Orthopaedica

Minimally clinically important improvement: all non-responders are not really non-responders an illustration from total knee replacement

(2012) A.M. Davis et al.   OSTEOARTHRITIS AND CARTILAGE

Quality of Data Entry Using Single Entry, Double Entry and Automated Forms Processing–An Example Based on a Study of Patient-Reported Outcomes

(2012) Aksel Paulsen et al.   PLoS One

Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multina

(2012) F. Tubach et al.   ARTHRITIS CARE & RESEARCH

Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)

(2012) Maxime Dougados et al.   ARTHRITIS RESEARCH & THERAPY

The failure of survivorship

(2011) V. Wylde et al.   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Patient-reported outcomes in the Swedish Hip Arthroplasty Register

(2011) O. Rolfson et al.   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Patient acceptable symptom state and OMERACT–OARSI set of responder criteria in joint replacement. Identification of cut-off values

(2011) A. Escobar et al.   OSTEOARTHRITIS AND CARTILAGE

Outcomes after total hip replacement based on patients' baseline status: What results can be expected?

(2011) Jose M. Quintana et al.   ARTHRITIS CARE & RESEARCH

Interpreting patient-reported outcome results: US FDA guidance and emerging methods

(2011) Lori D McLeod et al.   Expert Review of Pharmacoeconomics & Outcomes Research

A point of minimal important difference (MID): a critique of terminology and methods

(2011) Madeleine T King   Expert Review of Pharmacoeconomics & Outcomes Research

Health-related quality of life (EQ-5D) before and after orthopedic surgery

(2010) Karl-Åke Jansson et al.   Acta Orthopaedica

Responsiveness and minimal important differences after revision total hip arthroplasty

(2010) Hon-Yi Shi et al.   BMC MUSCULOSKELETAL DISORDERS

Joint registries

(2010) F. T. Horan   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics

(2010) Walter P. Maksymowych et al.   ARTHRITIS CARE & RESEARCH

Perception of improvement in patients with rheumatoid arthritis varies with disease activity levels at baseline

(2009) D. Aletaha et al.   ARTHRITIS AND RHEUMATISM

The variability in minimal clinically important difference and patient acceptable symptomatic state values did not have an impact on treatment effect estimates

(2009) Florence Tubach et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Identification of Cutpoints for Acceptable Health Status and Important Improvement in Patient-Reported Outcomes, in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

(2009) M. K. KVAMME et al.   JOURNAL OF RHEUMATOLOGY

Generation of a Danish TTO value set for EQ-5D health states

(2009) Kim U. Wittrup-Jensen et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiative

(2008) A.M. Davis et al.   OSTEOARTHRITIS AND CARTILAGE

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY